Published on February 28, 2019 By Jean-Pierre Ceccaldi

China allows the cultivation of Therapeutic Cannabis

Our sources in China have revealed that the Chinese government has just allowed three daughter companies of the pharmaceutical group Zhejiang Kangenbei from the Yunnan province to cultivate Cannabis for therapeutic use. They will be producing CBD from low THC plant varieties. This is an exclusive story from our partner in Europe, France Le Cannabiste.

* * *

This is information that's worth its weight in Cannabinoids. We have obtained this story from a very reliable source on the ground in China. The offices of the Chinese government from the Yunnan province have allowed three different companies to produce Cannabis, most likely, for the therapeutic compound CBD. 
#Yunnan Xi Nuo
The company Yunnan Xi Nuo Kang Biotechnology Ltd. has just received this Chinese production license on February 19, the document specifies that the license is valid until February 19, 2021. It's been is a "subsidiary of Zhejiang Kangenbei Group, which is wholly invested by Yunnan Xikang Biotechnology Co., Ltd. Sinokang was incorporated in Wenshan in July 2011 with a registered capital of 20 million yuan and increased to 60 million yuan in 2016."

This license specifies after verification that it will be allowed to produce Cannabis. "Da ma (大麻) = weed or therapeutic grass"

#Pike on the stock market
Yunnan Xi Nuo has an interesting line of activities as presented in its official online statement :

"Ginkgo tree planting as the core, planting and planting other Chinese herbal medicines and characteristic crops, and building an industry integrating planting, breeding, intermediate extraction, terminal product sales, leisure sightseeing and tourism"

Still according to our information Yunnan Xi Nu Biotechnology would certainly be undergoing a considerable growth, following this move.

* * *

Commentaires, réactions: Le Cannabiste sur Facebook / Twitter

Sources : Le Cannabiste //// Twitter //// 

Special thanks @ Stephane Waller and his sweet love

– Jean-pierre Ceccaldi pour The Blinc Group - Le Cannabiste 2018 Tous droits réservés –


Subscribe to our Blog


Join The Conversation



A few words from industry leaders

Quality control and compliance were our most important factors for choosing a hardware designer, producer and supplier. Blinc was chosen over others considered based on their reputation and experience for these key factors.
A team of rockstars across the board, from brand realignment to product development to training and support - big thank you!!!
The integrity of that medicine starts with the hardware that is used to deliver it and we knew that partnering with the Blinc Group was the best way to provide that kind of quality and reliability to our patients.
Working with Blinc Group was a completely seamless experience. Our team is very particular and detail-oriented, but Blinc was able to walk us through all our questions and queries to create a product we are stoked about.
The Blinc Group's unmatched customer service and supply chain diligence give us the peace of mind needed to provide our patients and customers with a quality product.
You guys are the best! Keep up the great work! We look forward to working more with Blinc as our hardware partner!
We could not be happier with our choice to work with The Blinc Group, and look forward to continue innovating with them in the future.
The alignment between our two companies is fantastic. Blinc takes safety and quality as seriously as we do, and the outcome of the working relationship has both teams excited...
The Blinc Group produces high quality products and provides great, attentive, and friendly customer service. We especially appreciate their documented attention to testing and compliance.
Fume Labs and the Blinc Group are incredible partners and we’re very fortunate to be working with them on our first product.